Trial · NCT00248651

Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Amitriptyline	97
Overall Study	STARTED	Escitalopram	98
Overall Study	STARTED	Placebo	97
Overall Study	Completed 12 Weeks of Treatment	Amitriptyline	78
Overall Study	Completed 12 Weeks of Treatment	Escitalopram	66
Overall Study	Completed 12 Weeks of Treatment	Placebo	75
Overall Study	COMPLETED	Amitriptyline	69
Overall Study	COMPLETED	Escitalopram	58
Overall Study	COMPLETED	Placebo	65
Overall Study	NOT COMPLETED	Amitriptyline	28
Overall Study	NOT COMPLETED	Escitalopram	40
Overall Study	NOT COMPLETED	Placebo	32

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00248651/flow